Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Johnstone

Showing results (181-190 of 352) with videos related to

Pageof 36
Sort By:
Leukemia|February 1, 2012
Histone deacetylase inhibitors are unable to synergize with ABT-737 in killing primary chronic lymphocytic leukaemia cells in vitroR Ralli, K M Banks, A P Wiegmans, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodiesAilsa J Christiansen, Alison West, Kellie-Marie Banks, et al.
The Biochemical Journal|December 15, 2000
Novel properties of the protein kinase CK2-site-regulated nuclear- localization sequence of the interferon-induced nuclear factor IFI 16L J Briggs, R W Johnstone, R M Elliot, et al.
The Analyst|April 7, 2010
A scalable and modular lab-on-a-chip genetic analysis instrumentG V Kaigala, M Behnam, A C E Bidulock, et al.
The Journal of Biological Chemistry|March 30, 2001
P-glycoprotein does not protect cells against cytolysis induced by pore-forming proteinsR W Johnstone, K M Tainton, A A Ruefli, et al.
Blood|April 12, 2014
Id2 represses E2A-mediated activation of IL-10 expression in T cellsFrederick Masson, Margherita Ghisi, Joanna R Groom, et al.
Cancer Research|October 26, 2013
An intact immune system is required for the anticancer activities of histone deacetylase inhibitorsAlison C West, Stephen R Mattarollo, Jake Shortt, et al.
Histochemistry and Cell Biology|January 28, 2003
Expression of IFI 16 in epithelial cells and lymphoid tissuesWu Wei, Christopher J P Clarke, Gino R Somers, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 7, 2002
Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosisCheryl A Conover, Edward W Johnstone, Russell T Turner, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 1, 1996
Obliteration of empyema tract with deepithelialized unipedicle transverse rectus abdominis myocutaneous flapJ M Serletti, R H Feins, A J Carras, et al.
Pageof 36

Showing results (181-190 of 352) with videos related to

Sort By:
Pageof 36
Leukemia|February 1, 2012
Histone deacetylase inhibitors are unable to synergize with ABT-737 in killing primary chronic lymphocytic leukaemia cells in vitroR Ralli, K M Banks, A P Wiegmans, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodiesAilsa J Christiansen, Alison West, Kellie-Marie Banks, et al.
The Biochemical Journal|December 15, 2000
Novel properties of the protein kinase CK2-site-regulated nuclear- localization sequence of the interferon-induced nuclear factor IFI 16L J Briggs, R W Johnstone, R M Elliot, et al.
The Analyst|April 7, 2010
A scalable and modular lab-on-a-chip genetic analysis instrumentG V Kaigala, M Behnam, A C E Bidulock, et al.
The Journal of Biological Chemistry|March 30, 2001
P-glycoprotein does not protect cells against cytolysis induced by pore-forming proteinsR W Johnstone, K M Tainton, A A Ruefli, et al.
Blood|April 12, 2014
Id2 represses E2A-mediated activation of IL-10 expression in T cellsFrederick Masson, Margherita Ghisi, Joanna R Groom, et al.
Cancer Research|October 26, 2013
An intact immune system is required for the anticancer activities of histone deacetylase inhibitorsAlison C West, Stephen R Mattarollo, Jake Shortt, et al.
Histochemistry and Cell Biology|January 28, 2003
Expression of IFI 16 in epithelial cells and lymphoid tissuesWu Wei, Christopher J P Clarke, Gino R Somers, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 7, 2002
Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosisCheryl A Conover, Edward W Johnstone, Russell T Turner, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 1, 1996
Obliteration of empyema tract with deepithelialized unipedicle transverse rectus abdominis myocutaneous flapJ M Serletti, R H Feins, A J Carras, et al.
Pageof 36